FibroGen
FGEN
$1.04
Share price
1.96%
Change (1 day)
-93.93%
Change (1 year)
Categories
P/S ratio for FibroGen (FGEN)
P/S ratio as of April 2024 (TTM): 0.6952
According to FibroGen's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.695233. At the end of 2023 the company had a P/S ratio of 0.5899.
P/S ratio history for FibroGen from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 0.5899 | -94.48% |
| 2022 | 10.7 | 92.52% |
| 2021 | 5.56 | -70.98% |
| 2020 | 19.1 | 30.65% |
| 2019 | 14.7 | -21.08% |
| 2018 | 18.6 | -31.97% |
| 2017 | 27.3 | 262.57% |
| 2016 | 7.53 | -27.94% |
| 2015 | 10.4 | -10.97% |
| 2014 | 11.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Illumina ILMN | 4.32 | 521.90% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 Accelerate Diagnostics AXDX | 1.67 | 140.35% | 🇺🇸 USA |